Where does MouseFunc rank among its competitors?

MouseFunc ranks 356th amongst 294 active competitors, of which 16 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Pixelgen Technolgies, which secured $15.5M in Aug, 2026.

Who are the top competitors of MouseFunc?

MouseFunc's top competitors include Sino Biological, GenScript and Pixelgen Technolgies. Among them, Pixelgen Technolgies secured the most recent funding round in August, 2026.

MouseFunc - 2026 Company Profile & Competitors

Company Details

Provider of antibodies and research reagents for laboratory analysis use. This entity offers various biological materials including recombinant proteins, ELISA kits, and polyclonal or monoclonal antibodies. These tools support scientific research and experimental studies in fields such as immunology and cell biology.

Key Metrics

Stage

Unfunded

Ranked

356^th among 356 competitors

Similar Companies

Sino Biological & 346 more

View MouseFunc's full profile

MouseFunc has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MouseFunc include Sino Biological, GenScript and Pixelgen Technolgies. Here is the list of Top 10 competitors of MouseFunc, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	63/100
2nd	GenScript 2002, Piscataway (United States), Public	Provider of reagents and instruments for life sciences research	$15M	Kleiner Perkins, Vermögensclub & 1 others	58/100
3rd	Pixelgen Technolgies 2020, Stockholm (Sweden), Series B	Developer of ground-breaking technologies for biomedical research and diagnostics	$21.5M	Flat Capital, Industrifonden & 2 others	56/100
4th	ITBMed 2016, Stockholm (Sweden), Series A	Developer of monoclonal antibodies to prevent transplant rejections	$87M	3E Bioventures Capital, Yonjin Capital & 2 others	54/100
5th	Mabtech 1986, Nacka (Sweden), Acquired	Develops antibodies and ELISA kits	-	Merieux Equity Partners, IK Partners & 1 others	53/100
6th	GeneTex 1997, Hsinchu (Taiwan), Early Stage	GeneTex is a manufacturer and supplier of bioreagents for life science research.	$4.3M	-	52/100
7th	Shanghai OPM Biosciences 2013, Pudong (China), Series B	Antibody culture media and vaccine culture products developer	$14.4M	CPE, China Life Great Health Fund & 5 others	51/100
8th	Icosagen 2005, Tartu (Estonia), Funding Raised	Products and services in custom antibody and protein production	-	EIC Fund, Europa	50/100
9th	Allele Biotech 1999, San Diego (United States), Series B	cGMP iPSCs and cell therapy CDMO accelerating regenerative medicine programs	$18M	NIH, HHS & 1 others	50/100
10th	Immuno-Biological Laboratories 1982, Fujioka (Japan), Public	Manufacture antibodies	-	Japan Asia Investment, Hokkaido Venture Capital ... & 3 others	49/100
356th	MouseFunc Unfunded	Provider of antibodies and research reagents for laboratory analysis use	-	-	-